Riley Fadden

Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients With Metastatic Melanoma

Alexander T. Faje, Ryan J. Sullivan, Donald P. Lawrence et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 483 citations · Full text

Medicine, Endocrinology, Oncology +16

High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma

Alexander T. Faje, Donald P. Lawrence, Keith T. Flaherty et al. · Cancer · 2018 · 483 citations · Full text

Life Sciences, Oncology, Pharmacology +13

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Evolution of delayed resistance to immunotherapy in a melanoma responder

David Liu, Jia‐Ren Lin, Emily Robitschek et al. · Nature Medicine · 2021 · 134 citations · Full text

Medicine, Immunology, Oncology +14

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

Michael Sang Hughes, Gabriel E. Molina, Steven T. Chen et al. · Journal for ImmunoTherapy of Cancer · 2019 · 98 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14